17:15 JST, April 16, 2022
BEIJING, April 16 (Reuters) – Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were approved for clinical trials as boosters in Hong Kong, the Sinopharm subsidiary said on Saturday.
Scientists worldwide are racing to study upgraded injections against Omicron, as data indicated that antibodies elicited by vaccines based on older strains show weaker activity to neutralize the highly transmissible variant.
The two candidates, both containing inactivated or “killed” Omicron virus and similar to the two Sinopharm vaccines in use in China, will be tested in adults who have already received two or three vaccine doses, CNBG said in a statement.
It did not specify which vaccine products the trial participants would have received before taking the experimental booster, or how many subjects would be recruited.
A Chinese study showed that a fourth dose of BBIBP-CorV, an existing Sinopharm vaccine, did not significantly lift antibody levels against Omicron when administered six months after a third booster dose to a regular two-dose regimen.
While the fourth dose did restore antibody levels to around the peak levels that followed the third dose, researchers said new vaccines would offer a better alternative as future boosters.
"News Services" POPULAR ARTICLE
-
UPDATE2: Four Japanese Self-Defense Forces members injured in explosion at U.S. Kadena Air Base in Japan’s Okinawa
-
Shooter Kills At Least Nine in Attack on Austrian School, Mayor Says
-
Liberal Lee Jae-Myung Projected to Win South Korea Election Overshadowed by Martial Law Crisis
-
Japan’s Nikkei Stock Average Ends Lower on Worries about US-China Trade Tension, Stronger Yen (UPDATE 1)
-
North Korea Fired Multiple-launch Rockets from Near Pyongyang, South Korea Says
JN ACCESS RANKING
-
Japanese Researchers Develop ‘Transparent Paper’ as Alternative to Plastics; New Material Is Biodegradable, Can Be Produced with Low Carbon Emissions
-
Average Retail Rice Price Up for Second Consecutive Week; More Than Double Same Period Last Year
-
Japan’s Cooperation in Alaska LNG Development Project Emerges in Japan-U.S. Tariff Negotiations; But Industry Concerns Exist
-
Vietnam, Thailand Aim to Grow Rice Exports to Japan
-
Japan’s Maglev Shinkansen’s Partially Completed Station Unveiled; Station Will Be Only Underground Stop Between Shinagawa, Nagoya